ロード中...
Safety evaluation of the food enzyme α‐amylase from the genetically modified Bacillus amyloliquefaciens strain DP‐Czb53
The food enzyme α‐amylase (4‐α‐d‐glucan glucohydrolase; EC 3.2.1.1) is produced with the genetically modified B. amyloliquefaciens strain DP‐Czb53 by Danisco US Inc. The genetic modifications do not raise safety concerns, except for the presence of a multicopy plasmid carrying known antimicrobial re...
保存先:
| 出版年: | EFSA J |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7592075/ https://ncbi.nlm.nih.gov/pubmed/33144885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2903/j.efsa.2020.6185 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|